Mitsubishi UFJ Trust & Banking
TARO

Mitsubishi UFJ Trust & Banking’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History

Mitsubishi UFJ Trust & Banking’s Portfolio TARO Stock Details TARO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-1,123
Closed -$27.3K – 1204
2023
Q1 		$27.3K Hold
1,123
– – ﹤0.01% 1125
2022
Q4 		$32.6K Hold
1,123
– – ﹤0.01% 1121
2022
Q3 		$34K Sell
1,123
-772
-41% -$26.6K ﹤0.01% 1128
2022
Q2 		$69K Sell
1,895
-1,005
-35% -$38.3K ﹤0.01% 1145
2022
Q1 		$125K Buy
2,900
+1,700
+142% +$79.4K ﹤0.01% 1239
2021
Q4 		$60K Hold
1,200
– – ﹤0.01% 1314
2021
Q3 		$76K Buy
+1,200
New +$83K ﹤0.01% 1317
2020
Q4 		– Sell
-900
Closed -$49K – 1366
2020
Q3 		$49K Sell
900
-900
-50% -$56K ﹤0.01% 1304
2020
Q2 		$120K Buy
1,800
+500
+38% +$33.5K ﹤0.01% 1207
2020
Q1 		$80K Hold
1,300
– – ﹤0.01% 1235
2019
Q4 		$114K Hold
1,300
– – ﹤0.01% 1256
2019
Q3 		$98K Buy
+1,300
New +$106K ﹤0.01% 1271
2017
Q4 		– Sell
-28,206
Closed -$3.18M – 816
2017
Q3 		$3.18M Buy
28,206
+23
+0.1% +$2.5K 0.01% 708
2017
Q2 		$3.16M Sell
28,183
-1,394
-5% -$157K 0.01% 703
2017
Q1 		$3.45M Sell
29,577
-547
-2% -$60.5K 0.01% 693
2016
Q4 		$3.17M Sell
30,124
-910
-3% -$95.3K 0.01% 697
2016
Q3 		$3.43M Buy
31,034
+852
+3% +$113K 0.01% 685
2016
Q2 		$4.39M Buy
30,182
+14,391
+91% +$2.04M 0.01% 683
2016
Q1 		$2.26M Buy
15,791
+370
+2% +$52.6K 0.01% 707
2015
Q4 		$2.38M Buy
+15,421
New +$2.25M 0.01% 709

Other funds holding TARO

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return

Mitsubishi UFJ Trust & Banking's TARO Position: Q2 2023 in Review

Mitsubishi UFJ Trust & Banking sold out of Taro Pharmaceutical Industries Ltd. (TARO) in Q2 2023, closing a stake of 1,123 shares — an estimated $27.3K sold.

Mitsubishi UFJ Trust & Banking first reported a position in TARO in Q4 2015 and held it in 20 quarters. The position peaked at $4.39M in Q2 2016. 71 funds tracked by Wall St. Rank hold TARO as of Q2 2023.

  • Mitsubishi UFJ Trust & Banking reported no remaining Taro Pharmaceutical Industries Ltd. position as of Q2 2023 after selling out during the quarter.
  • Mitsubishi UFJ Trust & Banking sold 1,123 Taro Pharmaceutical Industries Ltd. shares in Q2 2023, an estimated $27.3K.
  • Mitsubishi UFJ Trust & Banking first reported a position in Taro Pharmaceutical Industries Ltd. in Q4 2015 and held it in 20 quarters.
  • Mitsubishi UFJ Trust & Banking's Taro Pharmaceutical Industries Ltd. position peaked at $4.39M in Q2 2016.
  • 71 funds tracked by Wall St. Rank held Taro Pharmaceutical Industries Ltd. as of Q2 2023.

Based on Mitsubishi UFJ Trust & Banking's 13F filing for Q2 2023, filed 8 Aug 2023.